Drug Research
Amgen Eyeing Preclinical Blood Cancer Program to Its Skills
Amgen is going ahead and adding Dark Blue to its tapestry, embedding the preclinical blood cancer program of U.K. biotech into its organization.
The California pharma has...
Business & Industry
Daiichi Eyes Commercialization of its Leukemia Med Vanflyta
Daiichi Sankyo is now looking out for new horizons when it comes to its leukemia med Vanflyta, with Genesis Pharma signing to commercialize the drug...
Clinical Trials
B-Well 1 And B-Well 2 Phase III Trials Fare Well from GSK
GSK plc has announced positive results coming from its two pivotal phase III trials - the B-Well 1 and B-Well 2 phase III trials,...
Business & Industry
InduPro, Lilly Partner to Discover Novel Cancer Treatments
Shortly after going ahead and securing a partnership with Sanofi, InduPro is now linking up with Eli Lilly in its endeavors to discover novel...
Business & Industry
Nimbus, Lilly Ink Licence Agreement on Treatments in Obesity
Nimbus Therapeutics has announced that it has entered into a multi-year research partnership and a $1.3 billion exclusive license agreement with Eli Lilly in...
News
Liver Health in the Age of Processed Foods: What Supplements Can Support Recovery
When it comes to nutrition, convenience can be demanding. The consumption of ultra-processed food has become a dietary norm because it is easily available...
News
Science-Backed Natural Weight Loss Methods That Actually Work
Weight loss is no longer about the ability to fit into smaller clothes but a matter of serious national health consideration. The World Health...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read